• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[在西班牙实施戒烟干预措施对发病率、死亡率和医疗保健成本的影响]

[The effects of implementing a smoking cessation intervention in Spain on morbidity, mortality and health care costs].

作者信息

González-Enríquez J, Salvador-Llivina T, López-Nicolás A, Antón De Las Heras E, Musin A, Fernández E, García M, Schiaffino A, Pérez-Escolano I

机构信息

Agencia de Evaluación de Tecnologías Sanitarias, Instituto de Salud Carlos III, Madrid, Spain.

出版信息

Gac Sanit. 2002 Jul-Aug;16(4):308-17. doi: 10.1016/s0213-9111(02)71929-8.

DOI:10.1016/s0213-9111(02)71929-8
PMID:12106550
Abstract

OBJECTIVE

We estimated the effect that a smoking cessation intervention in the Spanish population of smokers would have on smoking-related morbidity, mortality and health care costs.

METHODS

We adopted the model Health and Economic Consequences of Smoking sponsored by the WHO Health Organization and developed by the The Lewin Group. The smoking cessation intervention proposed includes pharmacological treatment to 35% of smokers who are trying to quit smoking and obtains a quit rate of 7.2%. The diseases studied are: lung cancer, heart disease, stroke, chronic obstructive pulmonary disease, asthma exacerbation, and low birth weight. The smoking-related cases of disease and of averted death and the reduction in health care expenditure due to the intervention were estimated.

RESULTS

Without intervention, at year 1 of the model, 2,136,094 smokers would be affected by some smoking-related disease; health care expenditure would be 4,286 million e and deaths attributable to smoking would total 26,537. The proposed intervention would prevent 2,613, 9,192, 17,415 and 23,837 cases of smoking-related disease at years 2, 5, 10 and 20 of the model, respectively. The saving in accumulated health care costs would amount to 3.5 million e at year 2 and 386 million e over 20 years. The accumulated prevented deaths are 284 at year 2 and 9,205 over 20 years. The intervention would save a total of 78,173 life-years by the end of the period considered.

CONCLUSIONS

The availability of new effective smoking cessation interventions and the increase in accessibility to such interventions may contribute significantly to reducing morbidity, mortality and health care costs associated with smoking in Spain.

摘要

目的

我们评估了针对西班牙吸烟人群的戒烟干预措施对吸烟相关发病率、死亡率及医疗保健成本的影响。

方法

我们采用了由世界卫生组织赞助、莱文集团开发的“吸烟的健康与经济后果”模型。提议的戒烟干预措施包括为35%试图戒烟的吸烟者提供药物治疗,戒烟成功率为7.2%。所研究的疾病有:肺癌、心脏病、中风、慢性阻塞性肺疾病、哮喘加重以及低出生体重。我们估计了与吸烟相关的疾病病例、避免的死亡人数以及干预措施导致的医疗保健支出的减少。

结果

在模型的第1年,若不进行干预,2136094名吸烟者将受到某种吸烟相关疾病的影响;医疗保健支出将达42.86亿欧元,吸烟导致的死亡总数将为26537人。提议的干预措施在模型的第2年、第5年、第10年和第20年将分别预防2613例、9192例、17415例和23837例吸烟相关疾病。在第2年累计节省的医疗保健成本将达350万欧元,20年累计节省3.86亿欧元。在第2年累计预防的死亡人数为284人,20年累计为9205人。到所考虑时期结束时,该干预措施总共将挽救78173个生命年。

结论

新的有效戒烟干预措施的可得性以及此类干预措施可及性的提高,可能会显著有助于降低西班牙与吸烟相关的发病率、死亡率及医疗保健成本。

相似文献

1
[The effects of implementing a smoking cessation intervention in Spain on morbidity, mortality and health care costs].[在西班牙实施戒烟干预措施对发病率、死亡率和医疗保健成本的影响]
Gac Sanit. 2002 Jul-Aug;16(4):308-17. doi: 10.1016/s0213-9111(02)71929-8.
2
Cost-effectiveness of alternative smoking cessation scenarios in Spain: results from the EQUIPTMOD.西班牙不同戒烟方案的成本效益:EQUIPTMOD 研究结果。
Addiction. 2018 Jun;113 Suppl 1(Suppl Suppl 1):65-75. doi: 10.1111/add.14090. Epub 2018 Mar 13.
3
Cost-benefit analysis of funding smoking cessation before surgery.手术前戒烟的成本效益分析。
Br J Surg. 2020 Jul;107(8):978-994. doi: 10.1002/bjs.11506. Epub 2020 May 5.
4
Cost-effectiveness of varenicline versus bupropion, nicotine-replacement therapy, and unaided cessation in Greece.希腊伐伦克林与安非他酮、尼古丁替代疗法和非药物戒烟的成本效益比较。
Clin Ther. 2012 Aug;34(8):1803-14. doi: 10.1016/j.clinthera.2012.07.002. Epub 2012 Jul 20.
5
Estimates of costs for modelling return on investment from smoking cessation interventions.估算戒烟干预措施投资回报率模型的成本。
Addiction. 2018 Jun;113 Suppl 1(Suppl Suppl 1):32-41. doi: 10.1111/add.14091. Epub 2018 Mar 13.
6
Costs and benefits of smoking cessation aids: making a case for public reimbursement of nicotine replacement therapy in Australia.戒烟辅助工具的成本与效益:为澳大利亚尼古丁替代疗法的公共报销提供依据。
Tob Control. 2007 Aug;16(4):255-60. doi: 10.1136/tc.2006.017657.
7
German EstSmoke: estimating adult smoking-related costs and consequences of smoking cessation for Germany.德国 EstSmoke:估算德国与成人吸烟相关的成本和戒烟后果。
Addiction. 2018 Jan;113(1):125-136. doi: 10.1111/add.13956. Epub 2017 Sep 18.
8
The health care costs of smoking.吸烟的医疗保健成本。
N Engl J Med. 1997 Oct 9;337(15):1052-7. doi: 10.1056/NEJM199710093371506.
9
Estimating the public economic consequences of introducing varenicline smoking cessation therapy in South Korea using a fiscal analytic framework.使用财政分析框架估算在韩国引入伐尼克兰戒烟疗法的公共经济后果。
J Med Econ. 2018 Jun;21(6):571-576. doi: 10.1080/13696998.2018.1434183. Epub 2018 Feb 13.
10
Evaluating a collaborative smoking cessation intervention in primary care (ENTER): study protocol for a cluster-randomized controlled trial.评估初级保健中的协作戒烟干预措施(ENTER):一项整群随机对照试验的研究方案
Trials. 2015 Oct 9;16:447. doi: 10.1186/s13063-015-0977-6.

引用本文的文献

1
Cost-effectiveness analysis of text messaging to support health advice for smoking cessation.用于支持戒烟健康建议的短信成本效益分析。
Cost Eff Resour Alloc. 2021 Feb 15;19(1):9. doi: 10.1186/s12962-021-00262-y.
2
Cost-effectiveness of alternative smoking cessation scenarios in Spain: results from the EQUIPTMOD.西班牙不同戒烟方案的成本效益:EQUIPTMOD 研究结果。
Addiction. 2018 Jun;113 Suppl 1(Suppl Suppl 1):65-75. doi: 10.1111/add.14090. Epub 2018 Mar 13.
3
Development and application of an economic model (EQUIPTMOD) to assess the impact of smoking cessation.
开发和应用经济模型(EQUIPTMOD)评估戒烟的影响。
Addiction. 2018 Jun;113 Suppl 1(Suppl Suppl 1):7-18. doi: 10.1111/add.14001. Epub 2017 Sep 14.
4
[Cost-benefit of medical advice for quitting smoking in the Region of Murcia].[穆尔西亚地区戒烟医学建议的成本效益]
Aten Primaria. 2017 Aug-Sep;49(7):407-416. doi: 10.1016/j.aprim.2016.11.006. Epub 2017 Feb 4.
5
Budgetary impact analysis on funding smoking-cessation drugs in patients with COPD in Spain.西班牙慢性阻塞性肺疾病患者戒烟药物资金的预算影响分析。
Int J Chron Obstruct Pulmon Dis. 2015 Sep 24;10:2027-36. doi: 10.2147/COPD.S87597. eCollection 2015.
6
Cost and clinical consequences of smoking cessation in outpatients after cardiovascular disease: a retrospective cohort study.心血管疾病门诊患者戒烟的成本及临床后果:一项回顾性队列研究
Clinicoecon Outcomes Res. 2013 Aug 19;5:419-27. doi: 10.2147/CEOR.S43256. eCollection 2013.
7
[Working with our smoker patients in primary care. Analysis of cost-effectiveness].[在初级保健中与吸烟患者合作。成本效益分析]
Aten Primaria. 2012 Nov;44(11):659-66. doi: 10.1016/j.aprim.2012.02.013. Epub 2012 Jun 15.
8
[Effectiveness of a programme of intensive tobacco counselling by nursing professionals].[护理专业人员强化烟草咨询项目的效果]
Aten Primaria. 2006 Mar 31;37(5):266-72. doi: 10.1157/13086312.